Stuttgart, Germany

Xin Xiong

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.v.. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xin Xiong. Retrieved from https://idiyas.com/inventor/xin-xiong-fungaev3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Xin Xiong

Introduction

Xin Xiong is a notable inventor based in Stuttgart, Germany. He has made significant contributions to the field of biomaterials, particularly through his work on collagen. His innovative approach has led to advancements that could impact various medical applications.

Latest Patents

Xin Xiong holds a patent for "Isolated Nature-Identical Collagen." This invention concerns isolated collagen, detailing the method for its production and the isolation of collagen from collagen-containing tissues. The isolated collagen has potential uses in a biomatrix as an in vitro test system, as well as for tissue and organ replacement.

Career Highlights

Xin Xiong is affiliated with the Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., a leading research organization in Germany. His work at this institution has allowed him to explore and develop innovative solutions in the field of biomaterials.

Collaborations

Xin collaborates with esteemed colleagues, including Steffen Rupp and Heike Mertsching, who contribute to his research endeavors. Their combined expertise enhances the potential impact of their work in the scientific community.

Conclusion

Xin Xiong's contributions to the field of biomaterials, particularly through his patent on isolated collagen, showcase his innovative spirit and dedication to advancing medical technology. His work has the potential to significantly influence tissue and organ replacement therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…